| __timestamp | Bristol-Myers Squibb Company | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 347523000 |
| Thursday, January 1, 2015 | 5920000000 | 479514000 |
| Friday, January 1, 2016 | 4940000000 | 581861000 |
| Sunday, January 1, 2017 | 6411000000 | 1326361000 |
| Monday, January 1, 2018 | 6345000000 | 1197957000 |
| Tuesday, January 1, 2019 | 6148000000 | 1154111000 |
| Wednesday, January 1, 2020 | 11143000000 | 2215942000 |
| Friday, January 1, 2021 | 10195000000 | 1458179000 |
| Saturday, January 1, 2022 | 9509000000 | 1585936000 |
| Sunday, January 1, 2023 | 9299000000 | 1627594000 |
| Monday, January 1, 2024 | 11159000000 | 2606848000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bristol-Myers Squibb Company and Incyte Corporation have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Bristol-Myers Squibb has consistently increased its R&D budget, peaking in 2020 with a 145% increase from 2014. This commitment underscores their dedication to pioneering new treatments and maintaining a competitive edge.
Incyte Corporation, while smaller in scale, has shown a remarkable 368% growth in R&D spending over the same period. Their focused investment strategy highlights their ambition to carve out a niche in the pharmaceutical industry.
These trends reflect broader industry dynamics, where strategic R&D investments are crucial for long-term success.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Incyte Corporation or Madrigal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Incyte Corporation vs Jazz Pharmaceuticals plc
R&D Insights: How Incyte Corporation and Alpine Immune Sciences, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.